Quarterly report pursuant to Section 13 or 15(d)

Equity Securities (Details Narrative)

v3.24.1.1.u2
Equity Securities (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended 3 Months Ended
Nov. 30, 2023
Nov. 20, 2023
May 26, 2023
Mar. 31, 2023
Mar. 20, 2023
Apr. 25, 2022
Mar. 31, 2024
Dec. 31, 2023
Warrants outstanding             8,358,697 8,358,697
Warrants to purchase shares of Common Stock   3,472,095            
Warrant reduced description             from $21.20 to $2.82 per share upon closing of the March 2023 Offering  
Preferred stock authorized             10,000,000 10,000,000
Net cash proceeds from PIPE     $ 1.5          
Received net cash proceeds $ 2.0              
Offering expenses $ 0.3              
Underwriters discounts and offering expenses     $ 0.3          
Preferred stock par value             $ 0.0001 $ 0.0001
Exercise price per share   $ 2.82            
Reduced exercise price $ 0.6511 $ 0.6511            
Description of abeyance shares             the Holder left 2,730,000 shares in abeyance at the Company’s transfer agent to be delivered to the Holder at their request, which were then delivered to the Holder on January 8, 2024  
Warrants Member                
Warrants outstanding             0  
Common Stock and Preferred Stock                
Exercise price per share           $ 0.0001    
Warrants to purchase shares of Common Stock           235,849 235,849  
Net cash proceeds         $ 4.2 $ 4.3    
Underwriters' discounts and offering expenses         $ 0.8 $ 0.7    
Common stock, shares sold     458,555   85,000 56,161    
Pre funded           179,687    
Pre-funded warrants to purchase shares of Common Stock           179,687    
Warrants sold to purchase one share of common stock, Exercise price           $ 21.20 $ 21.20  
Warrant [Member]                
Warrants outstanding               8,358,697
Fair value, per share             $ 0.4108  
Warrants to purchase shares of Common Stock 3,472,095              
Warrants, expire date             April 2022  
Exercise price per share $ 0.6511              
Net cash proceeds $ 3.0              
Equity issuance cost $ 2.0     $ 0.1        
Series A Common Stock Warrants [Member]                
Warrants to purchase shares of Common Stock 3,707,944 3,707,944            
Exchange Series A Common Warrants to Series B Common Warrants 3,236,246 3,236,246            
Common and Pre-Funded Warrants [Member]                
Warrant units to purchase stocks     342,322          
Warrants to purchase shares of Common Stock         1,618,123      
Pre-funded warrants to purchase shares of Common Stock         1,533,123      
Warrants sold to purchase one share of common stock     342,322          
Exercise price     $ 0.0001   $ 0.0001      
PIPE | Warrants Member                
Warrant units to purchase stocks         1,618,123      
Exercise price         $ 2.82      
May 2023 | PIPE Common Warrants                
Warrants outstanding             800,877 800,877
Exercise price     2.16       $ 2.16  
Offering price     $ 2.285          
Warrant units to purchase stocks     800,877          
Warrants sold to purchase one share of common stock     800,877